tykhr
sign in
free sign up
Adverum Biotechnologies Inc
Biotechnology
Healthcare
ADVM
21.00 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
2.57
52 week high
8.48
high
2.60
52 week low
2.05
low
2.40
growth
-64.32 %
previous Close
2.54
P/E ratio
-2
market cap
98.60 M
div yield
0
usd
Sep 2024
qoq
revenue
1.00 M
0.00 %
net incoming
-27.13 M
-46.86 %
eps
-1.30 %
-46.07 %
eps surprise
0.76 %
net profit margin
-2713.40 %
-2713.00 %
operating incoming
-30.72 M
-5.64 %
net change in cash
-32.49 M
-45.80 %
cash on hand
92.85 M
-27.07 %
cost of revenue
890 K
-6.90 %
top